Your body has learned to function on fewer calories by slowing your resting metabolic rate
But also: there was an overall reduced risk of heart failure, and evidence that the kidneys were protected as well
Once on the market, Adlyxin (lixisenatide) had a relatively small footprint, partly because by 2016 many clinicians leaned toward the more potent GLP-1 RAs
If you have a known drug allergy, your doctor might start you on a lower dose to see how your body responds
This is significant: the largest telehealth weight loss platform is exiting compounding
Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,783 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment